Yuta Inoki

The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome

K. Kamei, M. Ogura, Mai Sato, 2022, Pediatric Nephrology.

Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome

A. Ishiguro, K. Kamei, M. Ogura, 2021, Pediatric Nephrology.

Expert consensus on vaccination in patients with inflammatory bowel disease in Japan

S. Hosomi, D. Tokuhara, R. Kunisaki, 2023, Journal of Gastroenterology.

Changes in patterns of infection associated with pediatric idiopathic nephrotic syndrome: a single-center experience in Japan.

A. Ishiguro, Takanori Funaki, K. Kamei, 2022, The Journal of pediatrics.

Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models

M. Eguchi, T. Mimura, H. Moritani, 2016, Experimental biology and medicine.